Table 2 Quality of critical care publications from the Eastern Mediterranean Region reflected by the sample size, study design, research fields, and journal assessment
Country | No. | Sample size median (range) | Study design | Most common research fieldsa | Journal Assessment | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
RCT N (%) | NRCT N (%) | Observational N (%) | Meta-analysis N(%) | Review N(%) | Research field N (%) | Research field N (%) | Research field N (%) | IF Mean (SD) | Journals with IF>3 (no) | H Index | |||
Afghanistan | 1 | 410 | 0 | 0 | 1 (100%) | 0 | 0 | ID 1 (100%) | N/A | N/A | 0.37 | 0 | 6 |
Bahrain | 11 | 100 (4–1579) | 0 | 0 | 9 (81.8%) | 0 | 2 (18.2%) | ID 3 (27.3%) | Q/S 3 (27.3%) | Resp 2 (18.2%) | 1.31 (1.7) | 1 | 3 |
Djibouti | 2 | 131 (18–244) | 0 | 0 | 2 (100%) | 0 | 0 | Epidem 1 (50%) | Heme 1 (50%) | N/A | 0 | 0 | 0 |
Egypt | 165 | 75 (15–7393) | 19 (11.5%) | 0 | 140 (84.8%) | 0 | 6 (3.6%) | ID 68 (41.2%) | Resp 24 (14.5%) | Renal 11 (6.7%) | 1.34 (1.3) | 16 | 28 |
Iran | 620 | 84 (4–18,682) | 129 (20.8%) | 27 (4.4%) | 439 (70.8%) | 3 (0.48%) | 22 (3.5%) | ID 132 (21.3%) | Resp 68 (11%) | Cardio 40 (6.5%) | 0.54 (1.9) | 13 | 33 |
Iraq | 8 | 222 (28–986) | 0 | 0 | 6 (75%) | 0 | 2 (25%) | ID 2 (25%) | Q/S 2 (25%) | Burns 2 (25%) | 1.32 (0.7) | 0 | 10 |
Jordan | 63 | 135 (6–10,792) | 1 (1.6%) | 1 (1.6%) | 58 (92.1%) | 0 | 3 (4.8%) | ID 14 (22.2%) | Epid 7 (11.1%) | Resp 6 (9.5%) | 1.61 (1.6) | 6 | 11 |
Kuwait | 26 | 94 (5–10,419) | 0 | 0 | 24 (92.3%) | 0 | 2 (7.7%) | ID 15 (57.7%) | Epid 3 (11.5%) | Q/S 2 (7.7%) | 1.63 (1.0) | 2 | 17 |
Lebanon | 42 | 66 (10–1506) | 0 | 3 (7.1%) | 32 (76.2%) | 0 | 7 (16.7%) | ID 10 (23.8%) | Resp 6 (14.3%) | Burn 5 (12%) | 2.00 (2.0) | 5 | 21 |
Libya | 5 | 423 (260–995) | 0 | 0 | 5 (100%) | 0 | 0 | ID 2 (40%) | Q/S 2 (40%) | Cardio 1 (20%) | 0.40 (0.4) | 0 | 1 |
Morocco | 39 | 145 (9–146) | 2 (5.1%) | 1 (2.6%) | 36 (92.3%) | 0 | 0 | ID 9 (23%) | Resp 4 (10.3%) | Q/S 4 (10.3%) | 1.9 (2.9) | 5 | 11 |
Oman | 16 | 65 (29–95) | 0 | 0 | 15 (93.8%) | 0 | 1 (6.3%) | ID 3 (18.8%) | Resp 2 (12.5%) | Epid 2 (12.5%) | 0.58 (1.1) | 0 | 10 |
Pakistan | 95 | 144 (3–5800) | 2 (2.1%) | 0 | 89 (93.7%) | 0 | 4 (4.2%) | ID 33 (34.7%) | Epid 10 (10.5%) | CV 9 (9.5%) | 1.0 (1.2) | 5 | 17 |
Palestine | 5 | 123 (13–275) | 0 | 0 | 5 (100%) | 0 | 0 | P/F 2 (40%) | ID 2 (40%) | CPR 1 (20%) | 1.13 (1.6) | 1 | 2 |
Qatar | 36 | 201 (36–1036) | 1 (2.8%) | 0 | 33 (91.7%) | 0 | 2 (5.6%) | ID 4(11%) | Epid 4 (11%) | Org Don 4 (11%) | 1.35 (1.1) | 1 | 11 |
Saudi Arabia | 273 | 130 (6–256,195) | 11 (4%) | 2 (0.73%) | 214 (78.4%) | 0 | 46 (16.9%) | ID 78 (28.5%) | Q/S 31 (11.4%) | Resp 23 (8.4%) | 1.7 (2.3) | 36 | 40 |
Sudan | 6 | 99 (85–139) | 0 | 0 | 6 (100%) | 0 | 0 | Epidem 3 (50%) | Resp 2 (33.3%) | Renal 1 (16.7%) | 0.36 (1.6) | 0 | 2 |
Somalia | 0 | 0 | 0 | 0 | 0 | 0 | 0 | N/A | N/A | N/A | 0 | 0 | 0 |
Syria | 3 | 80b | 0 | 0 | 2 (66.7%) | 0 | 1 (33.3%) | ID 1 (33.3%) | Q/S 1 (33.3%) | Admin 1 (33.3%) | 0 | 0 | 2 |
Tunisia | 102 | 101 (6–5872) | 6 (5.9%) | 1 (0.98%) | 90 (88.2%) | 3 (2.9%) | 2 (1.96%) | ID 60 (58.8%) | Resp 13 (12.7%) | Heme 7 (6.9%) | 1.9 (2.9) | 19 | 28 |
United Arab Emirates | 16 | 117 (18–386) | 1 (6.25%) | 0 | 12 (75%) | 0 | 3 (18.8%) | ID 4 (25%) | Q/S 2 (12.5%) | Trauma 2 (12.5%) | 1.46 (1.2) | 1 | 13 |
Yemen | 3 | 129 (25–387) | 0 | 0 | 3 (100%) | 0 | 0 | Q/S 1 (33.3%) | Education 1 (33.3%) | Cardio 1 (33.3%) | 0.47 (0.4) | 0 | 1 |